| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
338,370,000 |
| Market
Cap: |
104.14(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$221.81 - $333.53 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Hospitals |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 223 |
| Guru Rank Value : 5.4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile HCA Healthcare is a holding company. Through its subsidiaries, partnerships and joint ventures, Co. owns and operates hospitals and related health care entities. Most of Co.'s general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. Co.'s psychiatric hospitals provide therapeutic programs including child, adolescent and adult psychiatric care, adolescent and adult alcohol and drug abuse treatment and counseling.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
325 |
| Total Buy Value |
$0 |
$0 |
$0 |
$64,565 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
17,127 |
24,840 |
34,460 |
181,290 |
| Total Sell Value |
$5,331,831 |
$7,702,343 |
$10,295,179 |
$47,351,204 |
| Total People Sold |
5 |
7 |
8 |
17 |
| Total Sell Transactions |
6 |
9 |
12 |
33 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Whalen Kathleen M |
SVP & Chief Ethics Officer |
• – – |
2023-02-17 |
4 |
S |
$263.61 |
$457,097 |
D/D |
(1,734) |
9,962 |
|
-14% |
|
| Reiner Deborah M |
SVP - Mktg. & Communications |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$327,499 |
D/D |
(1,246) |
3,314 |
|
- |
|
| Reiner Deborah M |
SVP - Mktg. & Communications |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,560 |
4,560 |
|
- |
|
| Foster Jon M |
EVP and COO |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$2,041,741 |
D/D |
(7,768) |
22,910 |
|
- |
|
| Foster Jon M |
EVP and COO |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
19,740 |
30,678 |
|
- |
|
| Cohen Jeffrey E. |
SVP-Government Relations |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$434,212 |
D/D |
(1,652) |
5,914 |
|
- |
|
| Cohen Jeffrey E. |
SVP-Government Relations |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,560 |
7,566 |
|
- |
|
| Sowell Joseph A Iii |
SVP; Chief Development Officer |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$641,592 |
D/D |
(2,441) |
5,159 |
|
- |
|
| Sowell Joseph A Iii |
SVP; Chief Development Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
7,600 |
|
- |
|
| Cuffe Michael S. |
EVP and Chief Clinical Officer |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$1,112,339 |
D/D |
(4,232) |
28,751 |
|
- |
|
| Cuffe Michael S. |
EVP and Chief Clinical Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
12,160 |
32,983 |
|
- |
|
| Paslick P. Martin |
SVP and CIO |
• – – |
2023-02-17 |
4 |
D |
$262.84 |
$943,333 |
D/D |
(3,589) |
27,677 |
|
- |
|
| Paslick P. Martin |
SVP and CIO |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,120 |
31,266 |
|
- |
|
| Torres Kathryn A. |
SVP-Payer Contracting & Align. |
• – – |
2023-02-16 |
4 |
D |
$263.15 |
$649,191 |
D/D |
(2,467) |
22,480 |
|
- |
|
| Torres Kathryn A. |
SVP-Payer Contracting & Align. |
• – – |
2023-02-16 |
4 |
OE |
$101.16 |
$462,807 |
D/D |
4,575 |
24,947 |
|
- |
|
| Berres Jennifer |
SVP & Chief Human Res. Officer |
• – – |
2023-02-07 |
4 |
S |
$255.23 |
$1,020,912 |
D/D |
(4,000) |
7,392 |
|
-14% |
|
| Reiner Deborah M |
SVP - Mktg. & Communications |
• – – |
2023-02-03 |
4 |
S |
$257.61 |
$2,045,699 |
D/D |
(7,941) |
0 |
|
-10% |
|
| Mosier Sammie S |
SVP & Chief Nurse Executive |
• – – |
2023-02-03 |
4 |
D |
$258.08 |
$10,581 |
D/D |
(41) |
6,943 |
|
- |
|
| Mosier Sammie S |
SVP & Chief Nurse Executive |
• – – |
2023-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
138 |
6,984 |
|
- |
|
| Hazen Samuel N |
CEO |
• • – |
2023-02-03 |
4 |
D |
$258.08 |
$8,312,241 |
D/D |
(32,208) |
105,677 |
|
- |
|
| Hazen Samuel N |
CEO |
• • – |
2023-02-03 |
4 |
OE |
$68.96 |
$4,068,640 |
D/D |
59,000 |
137,885 |
|
- |
|
| Akdamar Erol R |
Group President |
• – – |
2023-02-03 |
4 |
D |
$258.08 |
$1,014,771 |
D/D |
(3,932) |
39,794 |
|
- |
|
| Akdamar Erol R |
Group President |
• – – |
2023-02-03 |
4 |
OE |
$45.30 |
$407,700 |
D/D |
9,000 |
43,726 |
|
- |
|
| Rutherford Bill B |
CFO and EVP |
• – – |
2023-02-03 |
4 |
S |
$258.19 |
$7,745,568 |
D/D |
(30,000) |
81,632 |
|
-10% |
|
| Akdamar Erol R |
Group President |
• – – |
2023-02-02 |
4 |
S |
$258.63 |
$775,891 |
D/D |
(3,000) |
34,726 |
|
-8% |
|
1692 Records found
|
|
Page 7 of 68 |
|
|
1.08 (0.35%) 
